| Application no. and date | 23176223.8 (espacenet) (Federated) (European Patent Register), 20120912 | | Patent/reg. no. and date | DK/EP 4252857, 20240925 | | Publication date | 20231004 | | Priority no. and date | US 201161535392 P, 20110916, US 201161559162 P, 20111114, US 201261641321 P, 20120502 | | EP pub. no. and date |
EP 4252857 20231004 | | Effective date | | | Applicant/owner | Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road
Tarrytown, NY 10591-6706, US | | Applicant ref. no. | | | Inventor | SWERGOLD, Gary,
New Rochelle, NY 10804, US | | Representative | | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61P 11/00 (2006.01) , A61P 27/02 (2006.01) , A61P 3/06 (2006.01) , A61P 43/00 (2006.01) , A61P 7/00 (2006.01) , A61P 9/00 (2006.01) , A61P 9/10 (2006.01) , C07K 16/40 (2006.01) | | Title | METHODS FOR REDUCING LIPOPROTEIN(A) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9) | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
